clinicalpainadvisor.com3d
Postherpetic Neuralgia Treatment: Crisugabalin Helps Reduce Daily Pain
Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.
Post-Herpetic Neuralgia Treatment Market Projected to Reach $1.38 Billion by 2034, Growing at a CAGR of 5.3% | Fact.MR Report
Increasing Aging Population and Treatment Awareness benefiting Post-Herpetic Neuralgia Treatment ProvidersRockville, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global post herpetic neuralgia treatment ...
Webinar on trigeminal neuralgia to be held on November 10
Join Naruvi Hospitals and The Hindu for a webinar on Trigeminal Neuralgia with expert doctors on November 10. Register now!
Webinar on trigeminal neuralgia held in Chennai
Learn about trigeminal neuralgia diagnosis and treatment options from experts at Naruvi Hospitals, Vellore in a webinar.
GlobalData on MSN9d
Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain
Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...
Medscape8d
Trigeminal Neuralgia: For One Nerve a Multitude of Treatments
Trigeminal neuralgia (TN) is one of the most severe forms of pain in human experience. It is also a treatable condition if recognized and managed properly. As for any painful diagnosis, treatment ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA
The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...
The Robot Report4d
ZAP Surgical Systems obtains $78M to commercialize gyroscopic radiosurgery platform
ZAP Surgical aims to enable healthcare providers to deliver high-quality treatment without high costs and infrastructural ...